Eupraxia Pharmaceuticals Inc Common Stock
Price & Volume
Stats
See moreOpen | $7.36 |
Previous Close | $7.50 |
Day Range | $7.36-$8.39 |
52W Range | $5.15-$9.32 |
Market Cap | $492.2M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.20 |
News
See moreYahoo Finance • 3 months ago
Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders
Yahoo Finance • 4 months ago
Eupraxia Pharmaceuticals to Present at Digestive Disease Week Annual Meeting
Yahoo Finance • 4 months ago
Eupraxia Pharmaceuticals Reports Positive Nine-Month Tissue Health and Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis
Yahoo Finance • 6 months ago
Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results
About
CEO | Dr. James A. Helliwell FRCPC, M.D. |
Address | 2067 Cadboro Bay Road, Victoria, BC, Canada, V8R 5G4 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 49 |